TherapeuticsMD (TXMD) Other Working Capital Changes (2016 - 2026)
TherapeuticsMD filings provide 17 years of Other Working Capital Changes readings, the most recent being -$266000.0 for Q1 2026.
- On a quarterly basis, Other Working Capital Changes fell 31.03% to -$266000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$260000.0, a 100.0% decrease, with the full-year FY2025 number at $19000.0, up 26.67% from a year prior.
- Other Working Capital Changes hit -$266000.0 in Q1 2026 for TherapeuticsMD, up from -$1.3 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $2.3 million in Q3 2023 to a low of -$1.4 million in Q4 2023.
- Median Other Working Capital Changes over the past 5 years was $6000.0 (2025), compared with a mean of -$84058.8.
- Biggest five-year swings in Other Working Capital Changes: tumbled 587.04% in 2022 and later surged 1361.94% in 2023.
- TherapeuticsMD's Other Working Capital Changes stood at -$235000.0 in 2022, then plummeted by 482.98% to -$1.4 million in 2023, then soared by 207.81% to $1.5 million in 2024, then tumbled by 185.85% to -$1.3 million in 2025, then surged by 79.02% to -$266000.0 in 2026.
- The last three reported values for Other Working Capital Changes were -$266000.0 (Q1 2026), -$1.3 million (Q4 2025), and $6000.0 (Q3 2025) per Business Quant data.